Similar articles for PMID: 10905597

Year	Number of Results
1960	1
1991	4
1992	1
1993	2
1994	3
1995	3
1996	7
1997	11
1998	23
1999	21
2000	18
2001	10
2002	5
2003	8
2004	6
2005	3
2006	1
2007	1
2009	5
2010	3
2011	2
2012	5
2013	3
2017	1
2020	1
2021	2
2024	0

1

Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C.

Guilera M, Forns X, Torras X, Enríquez J, Coll S, Solà R, Morillas R, Planas R, Ampurdanès S, Soler M, Costa J, Sáiz JC, Sánchez-Tapias JM, Rodés J. Guilera M, et al. J Hepatol. 2000 Jul;33(1):135-41. doi: 10.1016/s0168-8278(00)80170-1. J Hepatol. 2000. PMID: 10905597 Clinical Trial.

2

Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.

Czerwionka-Szaflarska M, Chrobot A, Szaflarska-Szczepanik A. Czerwionka-Szaflarska M, et al. Med Sci Monit. 2000 Sep-Oct;6(5):964-70. Med Sci Monit. 2000. PMID: 11208439

3

Relationship between biochemical and virological responses to interferon therapy in chronic hepatitis C infection. Consensus Interferon Study Group.

Pockros PJ, Tong M, Lee WM, van Leeuwen DJ, Keeffe EB, Bala K, Killenberg PG, Foust RT, Rosenblate HJ, Payne KM, Fromm H, Lesesne HR, Black M. Pockros PJ, et al. J Viral Hepat. 1998 Jul;5(4):271-6. doi: 10.1046/j.1365-2893.1998.00114.x. J Viral Hepat. 1998. PMID: 9751014 Clinical Trial.

4

Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.

Campistol JM, Esforzado N, Martínez J, Roselló L, Veciana L, Modol J, Casellas J, Pons M, de Las Cuevas X, Piera J, Oliva JA, Costa J, Barrera JM, Bruguera M. Campistol JM, et al. Nephrol Dial Transplant. 1999 Nov;14(11):2704-9. doi: 10.1093/ndt/14.11.2704. Nephrol Dial Transplant. 1999. PMID: 10534516 Clinical Trial.

5

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.

Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelnau C, Kilani A, Areias J, Auperin A, Benhamou JP, Degott C, Erlinger S. Marcellin P, et al. Ann Intern Med. 1997 Nov 15;127(10):875-81. doi: 10.7326/0003-4819-127-10-199711150-00003. Ann Intern Med. 1997. PMID: 9382365

6

Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients.

Brouwer JT, Nevens F, Kleter B, Elewaut A, Adler M, Brenard R, Chamuleau RA, Michielsen PP, Pirotte J, Hautekeete ML, Weber J, Bourgeois N, Hansen BE, Bronkhorst CM, ten Kate FJ, Heijtink RA, Fevery J, Schalm SW. Brouwer JT, et al. J Hepatol. 1998 Jun;28(6):951-9. doi: 10.1016/s0168-8278(98)80342-5. J Hepatol. 1998. PMID: 9672169 Clinical Trial.

7

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.

Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, Shiffman ML, Zeuzem S, Craxi A, Ling MH, Albrecht J. Davis GL, et al. N Engl J Med. 1998 Nov 19;339(21):1493-9. doi: 10.1056/NEJM199811193392102. N Engl J Med. 1998. PMID: 9819447 Free article. Clinical Trial.

8

Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.

Samuel D, Bizollon T, Feray C, Roche B, Ahmed SN, Lemonnier C, Cohard M, Reynes M, Chevallier M, Ducerf C, Baulieux J, Geffner M, Albrecht JK, Bismuth H, Trepo C. Samuel D, et al. Gastroenterology. 2003 Mar;124(3):642-50. doi: 10.1053/gast.2003.50095. Gastroenterology. 2003. PMID: 12612903 Clinical Trial.

9

Comparison of thrice weekly vs daily human leucocyte interferon-alpha therapy for chronic hepatitis C. TVVH Study Group.

Chemello L, Cavalletto L, Bernardinello E, Boccato S, Casarin P, Cavinato F, Urban F, Pontisso P, Cecchetto A, Gatta A, Alberti A. Chemello L, et al. J Viral Hepat. 1999 Jul;6(4):321-7. doi: 10.1046/j.1365-2893.1999.00165.x. J Viral Hepat. 1999. PMID: 10607247 Clinical Trial.

10

Discordance between serum alanine aminotransferase (ALT) and virologic response to IFN-alpha2b in chronic hepatitis C patients with high and low pretreatment serum hepatitis C virus RNA titers.

Blatt LM, Tong MJ, McHutchison JG, Russell J, Schmid P, Conrad A. Blatt LM, et al. J Interferon Cytokine Res. 1998 Feb;18(2):75-80. doi: 10.1089/jir.1998.18.75. J Interferon Cytokine Res. 1998. PMID: 9506457

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

149 results

Results by year